1. Introduction {#sec1}
===============

The scope of contemporary metabolic engineering has expanded over the years through the adoption of non-conventional microorganisms, domesticated *via* synthetic biology strategies ([@bib1]; [@bib14]; [@bib28]; [@bib45]; [@bib54]; [@bib91]). Key to this development is the use of advanced genome engineering techniques ([@bib29]; [@bib52]), often based on the temporary propagation of plasmids. Such approaches include CRISPR/Cas9 technologies ([@bib4]; [@bib10]; [@bib20]; [@bib43]; [@bib97]), DNA recombineering ([@bib7]; [@bib22]; [@bib93]), and homologous recombination-based DNA editing ([@bib19]; [@bib63]; [@bib104]). A dedicated synthetic biology toolbox enabled the taming of *Pseudomonas* species (and, in particular, of *P*. *putida* strain KT2440) as robust platforms for bioproduction ([@bib48]; [@bib60]; [@bib78]; [@bib108], [@bib72]; [@bib84]; [@bib92]).

Homologous recombination is the standard principle to insert heterologous DNA fragments into (or deleting parts of) the genome of *Pseudomonas* species ([@bib76]). This methodology, established for *P*. *putida* by [@bib61], typically involves two rounds of recombination. A first cycle consists in the chromosomal integration of a suicide plasmid containing recognition sequence(s) for the I-*Sce*I homing meganuclease ([@bib30]; [@bib42]; [@bib44]). Next, a helper plasmid, encoding elements needed to introduce double-strand breaks (DSBs) in the chromosome, is transformed into co-integrants. The second recombination event, forced by DSBs (which would be otherwise lethal), uses duplicated sequences in the (co-integrated) plasmid as substrate ([@bib85]). Such recombination-and-resolving step results in the stochastic occurrence of revertant clones (displaying the wild-type genotype) and mutant clones carrying the desired modification---e.g. deletion, insertion, or point mutation. After creating the mutation intended, the helper plasmid used for introducing DSBs should be cured prior to any subsequent experiment. Vector curing is also beneficial for successive genome engineering manipulations, as the presence of helper plasmids drastically reduces the efficiency of subsequent integration events---likely because of the basal expression of the gene encoding the DSB-inducing enzyme ([@bib12]).

The plasmid-curing step is the most time-consuming part of bacterial genome engineering protocols; generally accomplished by repetitive passaging of clones in antibiotic-free culture media (loss-by-dilution) followed by sensitivity screening against the antibiotic marker of the helper plasmid ([@bib5],[@bib6]; [@bib67]). From a broader perspective, the removal of plasmid DNA from a given bacterial host is a standard technique in microbiology, and different strategies have been implemented for this purpose ([@bib34]; [@bib99]). Originally designed for *Escherichia coli* and related species, such protocols comprise electroporation ([@bib38]), use of DNA intercalating reagents ([@bib13]), adoption of conditionally-replicating plasmids and repetitive passaging under non-selective conditions ([@bib17]), and CRISPR/Cas9-mediated plasmid killing ([@bib58]). These methodologies, however, often yield uneven results when implemented in *Pseudomonas* species. The most convenient technique thus far is the use of temperature-sensitive plasmids, based on the RK2 ([@bib100]) and pSC101 ([@bib36]) vegetative origins of replication (*oriV*). Unfortunately, the narrow-host-range *oriV*(pSC101) does not replicate in pseudomonads, while *oriV*(RK2) exhibits altered temperature-sensitive characteristics depending on the species ([@bib50]). No temperature-sensitive *oriV* is known to be fully functional in *P*. *putida*, and temperature shifts could anyways be lethal to some mutants ([@bib40])---thus precluding the broad use of temperature-sensitive replicons as a strategy for plasmid curing.

On this background, here we describe a plasmid-based system designed for efficient vector curing in *Pseudomonas* species, based on synthetic control of plasmid replication. In particular, the replication of plasmids carrying the gene encoding the I-*Sce*I meganuclease has been made strictly dependent on the presence of the chemical inducer 3-methylbenzoate (3-*m*Bz). These new vectors are rapidly and irreversibly lost in the absence of 3-*m*Bz, and screening of bacterial clones that have lost the plasmid is facilitated by using fluorescent markers. We demonstrate the ease of genome engineering with this system by deleting ten individual genomic regions in the platform *P. putida* strain EM42 encoding functions deemed dispensable for metabolic engineering applications (i.e. all β-lactamase--like genes, *benABCD*, and *pvdD*; together accounting for \~23 ​kb) towards a reduced-genome *chassis* of reference.

2. Materials and methods {#sec2}
========================

2.1. Bacterial strains and growth conditions {#sec2.1}
--------------------------------------------

All bacterial strains used in this study are listed in [Table 1](#tbl1){ref-type="table"}. Cultures of *P. putida* KT2440, *E*. *coli* and their derivatives were incubated at 30 ​°C and 37 ​°C, respectively. For standard applications, routine cloning procedures, and during genome engineering manipulations, cells were grown in lysogeny broth (LB) medium (10 ​g ​L^−1^ tryptone, 5 ​g ​L^−1^ yeast extract, and 10 ​g ​L^−1^ NaCl). All liquid cultures were agitated at 200 ​rpm (MaxQ™ 8000 incubator; ThermoFisher Scientific, Waltham, MA, USA). Solid culture media also contained 15 ​g ​L^−1^ agar. Kanamycin (Km), gentamicin (Gm), streptomycin (Str), and ampicillin (Amp) were added whenever needed at 50 ​μg ​mL^−1^, 10 ​μg ​mL^−1^, 100 ​μg ​mL^−1^, and 100 ​μg ​mL^−1^, respectively. Unless indicated otherwise, Amp was supplemented at 500 ​μg ​mL^−1^ in *P*. *putida* cultures. For quantification of red and green fluorescence and phenotypic characterization of reduced-genome strains, *P*. *putida* KT2440, EM42, and derivatives thereof were grown in M9 minimal medium ([@bib73], [@bib77]) supplemented with 0.2% (w/v) citrate in 96-well plates in a Synergy HI plate reader (BioTek Instruments; Winooski, VT, USA). The excitation and emission wavelengths (λ~excitation~/λ~emission~) used for detection of mRFP/mCherry (red) and msfGFP (green) fluorescence were 488 nm/588 ​nm and 485 nm/528 ​nm, respectively.Table 1Bacterial strains and plasmids used in this study.Table 1NameRelevant characteristics[a](#tbl1fna){ref-type="table-fn"}Source or referenceBacterial strain*E*. ​*coli* DH5αCloning host; F^−^ λ^--^*endA1 glnX44*(AS) *thiE1 recA1 relA1 spoT1 gyrA96*(Nal^R^) *rfbC1 deoR nupG* Φ80(*lacZ*Δ*M15*) Δ(*argF*-*lac*)*U169 hsdR17*(*r*~*K*~^--^*m*~*K*~^*+*^)[@bib69]*E*. ​*coli* DH5α λ*pir*Cloning host; λ*pir* lysogen derivative of strain DH5α[@bib83]*P*. ​*putida* KT2440Wild-type strain; derivative of *P*. *putida* mt-2 ([@bib105]) cured of the TOL plasmid pWW0[@bib8]*P*. ​*putida* EM42Reduced-genome derivative of *P*. ​*putida* KT2440; Δ*PP_4329*-*PP_4397* (flagellar operon) Δ*PP_3849-PP_3920* (prophage I) Δ*PP_3026-PP_3066* (prophage II) Δ*PP_2266-PP_2297* (prophage III) Δ*PP_1532-PP_1586* (prophage IV) ΔTn*7* Δ*endA-1* Δ*endA-2* Δ*hsdRMS* ΔTn*4652*[@bib65]*P*. ​*putida* SEM10Reduced-genome derivative of *P*. ​*putida* EM42; Δ*PP_0052* Δ*PP_0772* Δ*PP_1239* Δ*PP_1775* Δ*PP_1952* Δ*PP_2045* Δ*PP_2876* Δ*PP_3291* Δ*benABCD* Δ*pvdD*This workPlasmidpSEVA637MCloning vector; *oriV*(pBBR1), promoter-less *msfGFP*; Gm^R^[@bib66]pS6313·GFPReporter plasmid; *oriV*(pBBR1), *P*~*EM7*~→*msfGFP*; Gm^R^This workpS2313·GFPReporter plasmid; *oriV*(pBBR1), *P*~*EM7*~→*msfGFP*; Km^R^This workpS6313·GFPsDerivative of vector pS6313·GFP with an engineered I-*Sce*I recognition site; Gm^R^This workpS2313·GFPsDerivative of vector pS2313·GFP with an engineered I-*Sce*I recognition site; Km^R^This workpSEVA628SHelper plasmid; *oriV*(RK2), XylS/*Pm*→*I-SceI*; Gm^R^[@bib3]pSEVA228SHelper plasmid; *oriV*(RK2), XylS/*Pm*→*I-SceI*; Km^R^[@bib3]pSEVA128SHelper plasmid; *oriV*(RK2), XylS/*Pm*→*I-SceI*; Amp^R^[@bib3]pJBSD1Conditionally-replicating vector; *oriV*(RK2), XylS/*Pm*→*trfA*; Amp^R^[@bib51]pS628SRDerivative of vector pSEVA628S with *P*~*14g*~*(BCD2)*→*mRFP*; Gm^R^This workpS228SRDerivative of vector pSEVA228S with *P*~*14g*~*(BCD2)*→*mRFP*; Km^R^This workpS628SR·MDerivative of vector pSEVA628S with *P*~*EM7*~→*mRFP*; Gm^R^This workpS228SR·MDerivative of vector pSEVA228S with *P*~*EM7*~→*mRFP*; Km^R^This workpS628SR·LDerivative of vector pSEVA628S with *P*~*EM7*~→*mCherry*; Gm^R^This workpS228SR·LDerivative of vector pSEVA228S with *P*~*EM7*~→*mCherry*; Km^R^This workpQURE1·HConditionally-replicating vector; derivative of vector pJBSD1 carrying XylS/*Pm*→*I-SceI* and *P*~*14g*~*(BCD2)*→*mRFP*; Amp^R^This workpQURE2·HConditionally-replicating vector; derivative of vector pJBSD1 carrying XylS/*Pm*→*I-SceI* and *P*~*14g*~*(BCD2)*→*mRFP*; Km^R^This workpQURE6·LConditionally-replicating vector; derivative of vector pJBSD1 carrying XylS/*Pm*→*I-SceI* and *P*~*14g*~→*mCherry*; Gm^R^This workpQURE6·MConditionally-replicating vector; derivative of vector pJBSD1 carrying XylS/*Pm*→*I-SceI* and *P*~*14g*~→*mRFP*; Gm^R^This workpQURE6·HConditionally-replicating vector; derivative of vector pJBSD1 carrying XylS/*Pm*→*I-SceI* and *P*~*14g*~*(BCD2)*→*mRFP*; Gm^R^This workpGNW2·mCherrySuicide vector used for deletions in Gram-negative bacteria; *oriT*, *traJ*, *lacZ*α, *ori*(R6K), *P*~*EM7*~→*mCherry*; Km^R^[@bib104]pGNW2Suicide vector used for deletions in Gram-negative bacteria; *oriT*, *traJ*, *lacZ*α, *ori*(R6K), *P*~*EM7*~→*msfGFP*; Km^R^[@bib104]pGNW·Δ*benABCD*Derivative of vector pGNW2 carrying HRs to delete *benABCD* (*PP_3161-PP_3164*); Km^R^This workpGNW2·LPODerivative of vector pGNW2 carrying HRs to insert *P*~*14g*~*(BCD2)*→*mOrange2* into a landing pad in the chromosome of *P*. *putida* KT2440; Km^R^[@bib104]pGNW4Derivative of vector pGNW2; Str^R^[@bib104]pGNW6Derivative of vector pGNW2; Gm^R^[@bib104]pSNW2Derivative of vector pGNW2 with *P*~*14g*~*(BCD2)*→*msfGFP*; Km^R^This workpSNW4Derivative of vector pGNW4 with *P*~*14g*~*(BCD2)*→*msfGFP*; Str^R^This workpSNW6Derivative of vector pGNW6 with *P*~*14g*~*(BCD2)*→*msfGFP*; Gm^R^This workpSNW·Δ*PP_1952*Derivative of vector pSNW2 carrying HRs to delete *PP_1952*; Km^R^This workpSNW·Δ*PP_3291*Derivative of vector pSNW2 carrying HRs to delete *PP_3291*; Km^R^This workpSNW·Δ*PP_2876*Derivative of vector pSNW2 carrying HRs to delete *PP_2876*; Km^R^This workpSNW·Δ*PP_2045*Derivative of vector pSNW2 carrying HRs to delete *PP_2045*; Km^R^This workpSNW·Δ*PP_0052*Derivative of vector pSNW2 carrying HRs to delete *PP_0052*; Km^R^This workpSNW·Δ*PP_1775*Derivative of vector pSNW2 carrying HRs to delete *PP_1775*; Km^R^This workpSNW·Δ*PP_1239*Derivative of vector pSNW2 carrying HRs to delete *PP_1239*; Km^R^This workpSNW·Δ*PP_0772*Derivative of vector pSNW2 carrying HRs to delete *PP_0772*; Km^R^This workpSNW·Δ*pvdD*Derivative of vector pSNW2 carrying HRs to delete *pvdD* (*PP_4219*); Km^R^This workpSNW·Δ*benABCD*Derivative of vector pSNW2 carrying HRs to delete *benABCD* (*PP_3161-PP_3164*); Km^R^This work[^1]

2.2. General cloning procedures and plasmid construction {#sec2.2}
--------------------------------------------------------

All plasmids and oligonucleotides used in this work are listed in [Table 1](#tbl1){ref-type="table"} and [Table S1](#appsec1){ref-type="sec"} (Supplementary Material), respectively. Unless stated otherwise, uracil-excision (*USER*) cloning ([@bib16]) was used for the construction of all plasmids. The *AMUSER* tool was employed for the design of oligonucleotides ([@bib32]). Phusion™ *U* and Phusion™ Hot Start II high-fidelity DNA polymerases (ThermoFisher Scientific) were used according to the manufacturer's specifications for amplifications intended for *USER* cloning or site-directed PCR mutagenesis, respectively. For colony PCR, the commercial *OneTaq*™ master mix (New England BioLabs; Ipswich, MA, USA) was used according to the manufacturer's instructions. *E. coli* DH5α was employed for general cloning purposes, while *E. coli* DH5α λ*pir* was employed when cloning and maintaining replicons with the conditional, Π-dependent origin of replication *RK6* ([Table 1](#tbl1){ref-type="table"}). Chemically-competent *E*. *coli* cells were prepared and transformed with plasmids according to well established protocols ([@bib89]). *P*. *putida* was rendered electrocompetent by washing the biomass from saturated (24 ​h) LB medium cultures with 0.3 ​M sucrose, and cells were routinely transformed with plasmids by electroporation, following the protocols of [@bib41] and [@bib18]. Site-directed PCR mutagenesis was used for insertion of I-*Sce*I restriction sites into selected plasmids with procedures described elsewhere ([@bib102]). The identity and correctness of all plasmids and DNA constructs were confirmed by sequencing.

In the following description, the letter *x* is used as a place-holder in plasmid nomenclature, standing for Amp^R^ (1), Km^R^ (2), and Gm^R^ (6). Note that the numbers identifying these resistance determinants are coded as for the rules set in the *Standard European Vector Architecture* (SEVA; [@bib95]). In order to construct plasmids pS*x*28SR·L (low level of red fluorescence), the fragment containing *mCherry* under transcriptional control of the constitutive *P*~*EM7*~ promoter ([@bib75]) was amplified from vector pGNW2·mCherry with the primer pair RED-low-F and RED-low-R. Similarly, to construct plasmids pS*x*28SR·M and pS*x*28SR (displaying, respectively, medium and high levels of red fluorescence), the fragments containing *mRFP* under transcriptional control of *P*~*EM7*~ or *P*~*14g*~ \[a synthetic, constitutive and strong derivative of the *P*~*EM7*~ promoter ([@bib107])\] were amplified from plasmids pSEVA2313R and pGNW2∙LPO with the primer pairs RED-medium-F/RED-medium-R and RED-F/RED-R, respectively. In parallel, plasmids pS*x*28S were reverse-amplified with the oligonucleotide pair Ins-RED-F and Ins-RED-R. These fragments were used as the backbone, and stitched with the previously-generated *mCherry*- or *mRFP*-bearing DNA fragments by *USER* cloning to yield the corresponding plasmids ([Table 1](#tbl1){ref-type="table"}).

For the construction of plasmid pQURE1, a DNA fragment bearing both the *I-SceI* gene under the transcriptional control of a XylS/*Pm* element and the *mRFP* gene under control of *P*~*14g*~ was amplified from plasmid pS228SR with oligonucleotides pQURE-F and pQURE-R. The resulting amplicon was joined with the fragment resulting from the reverse amplification of vector pJBSD1 with the primer pair Ins-pQURE-F and Ins-pQURE-R. Plasmids pQURE2 and pQURE6 were generated, respectively, by exchanging the antibiotic cassette present in plasmid pQURE1 (Amp^R^) by either a Km^R^ or a Gm^R^ marker. To this end, vector pQURE1 was reverse-amplified with the primer pair Ins-pQURE-Ab-F and Ins-pQURE-Ab-R, while individual antibiotic cassettes were amplified with oligonucleotides Ab-F and Ab-R from vectors pSEVA228S and pSEVA628S. The individual fragments were then ligated by *USER* cloning as indicated above.

Plasmid pS6313·GFP, carrying a synthetic *P*~*EM7*~→*msfGFP* element, was constructed through site-directed PCR mutagenesis of plasmid pSEVA637M with the primer pair *P*~*EM7*~-Ins-F and *P*~*EM7*~-Ins-R. Furthermore, the I-*Sce*I restriction site (5′-TAG GGA TAA CAG GGT AAT-3′) was engineered into this vector by a subsequent round of site-directed PCR mutagenesis with oligonucleotides I-*Sce*I-Ins-F and I-*Sce*I-Ins-R, yielding plasmid pS6313·GFPs. Finally, suicide vector pSNW2 and derivatives thereof, designed for quick genome engineering of *Pseudomonas*, were constructed by amplification of a fragment containing the *P*~*14g*~ promoter and a bicistronic design (*BCD2*, adopted as a translational coupler) element from plasmid pGNW2∙LPO with the primer pair *P*~*14g*~-F and BCD2-R. Plasmids pGNW2, pGNW4, and pGNW6 were reverse-amplified with oligonucleotides GFP4BCD2-F and EMG4GFP-R. The resulting fragments were assembled by *USER* cloning, giving rise to the suicide vectors pSNW2 (Km^R^), pSNW4 (Str^R^), and pSNW6 (Gm^R^), respectively.

2.3. Target-curing of plasmids by *in vivo* meganuclease digestion {#sec2.3}
------------------------------------------------------------------

The *P*. *putida* strain harboring the plasmid to be cured was co-transformed with a helper plasmid bearing the I-*Sce*I activity (e.g. plasmid pSEVA228S) by electroporation. A 10-mL aliquot of LB medium supplemented with the appropriate antibiotics to select for both plasmids was then inoculated with the resulting strain, and the cells were grown overnight as indicated above. A 100-μL aliquot of this culture was then used to inoculate 10 ​mL of fresh LB medium supplemented with 2 ​mM 3-*m*Bz and the antibiotic needed to select only for the *I-SceI*--bearing plasmid (e.g. Km, when using plasmid pSEVA228S). The culture was incubated for 24 ​h and aliquots were then plated on solid media and inspected for plasmid loss as specified in the text.

2.4. Quick genome engineering of *P*. *putida* using self-curing vectors {#sec2.4}
------------------------------------------------------------------------

For the deletion of genes from the genome of *P*. *putida*, 500-bp DNA fragments upstream and downstream of the corresponding target to be eliminated were individually amplified from the genome of strain KT2440 with the corresponding pairs of oligonucleotides as specified in [Table S1](#appsec1){ref-type="sec"}. Km^R^-vector pSNW2 was used in all cases, and the addition of the upstream and downstream homology regions to this backbone resulted in the corresponding suicide vectors (indicated as pSNW·Δ*gene* in [Table 1](#tbl1){ref-type="table"}) for deleting each locus. The protocol of [@bib104] was followed for genomic co-integration of the suicide vectors. Successful integration of the suicide pSNW plasmids into the target locus was confirmed by (i) green fluorescence of individual colonies inspected under blue light and (ii) colony PCR of selected amplicons ([@bib61]). One such colony was inoculated in 10 ​mL of LB medium and incubated overnight as indicated above. This culture was used to prepare competent cells by thoroughly washing the biomass with 0.3 ​M sucrose, and these cells were transformed by electroporation with plasmid pQURE1 or its derivatives. Cell suspensions were recovered at least for 2 ​h in LB medium containing 2 ​mM 3-*m*Bz, and a loopfull of this culture was streaked onto LB medium agar containing 2 ​mM 3-*m*Bz and the corresponding antibiotic(s), and incubated overnight or until discernible colonies appeared on the agar surface. Deletion of target gene(s) was confirmed in msfGFP^--^ clones by colony PCR, and 5 ​mL of fresh LB medium (i.e. no additives) were inoculated with a single colony and incubated for 2 to 10 ​h under the same conditions. This culture was then diluted by streaking onto solid media (according to the nutritional needs of the mutants; solid LB medium was routinely used) to obtain isolated colonies. Non-fluorescent colonies (i.e. clones that have lost both msfGFP and mRFP/mCherry fluorescence when examined under blue light) were picked and inoculated in 5 ​mL of liquid LB medium. The loss of the plasmid was finally confirmed by parallel inoculation of liquid medium with the corresponding antibiotic(s), and all relevant genotypes were checked by DNA sequencing.

2.5. Ampicillin sensitivity assay {#sec2.5}
---------------------------------

Cultures of *P*. *putida* EM42 and SEM10 were grown overnight in 10 ​mL of LB medium. These cultures were diluted to an optical density measured at 600 ​nm (OD~600~) of 1 before serial dilutions were prepared with fresh LB medium. A 5-μL aliquot of each dilution was then spotted on plates containing various Amp concentrations (up to 75 ​μg ​mL^−1^). Plates were then incubated overnight and colonies were counted in each spot to estimate antibiotic sensitivity.

3. Results and discussion {#sec3}
=========================

3.1. Target-curing of plasmids in P. putida through *in vivo* meganuclease digestion {#sec3.1}
------------------------------------------------------------------------------------

During our current efforts to engineer *P*. *putida* for several applications, we often found it difficult to eliminate plasmids and vectors from this bacterium (especially if an engineered strain displays slow growth, rendering the plasmid loss-by-dilution approach impractical or simply impossible). Here, we chose the intron-encoded meganuclease I-*Sce*I from yeast to selectively introduce DSBs into targeted plasmids *in vivo*---therefore impeding further replication. Plasmids to be removed through this protocol are easily modified by insertion of the asymmetric, 18-bp--long I-*Sce*I recognition site into a conserved region present in all SEVA plasmids within the antibiotic resistance marker and the *oriT* (origin of transfer) module ([Fig. 1](#fig1){ref-type="fig"}A). A one-step, site-directed PCR mutagenesis of any SEVA vector can be used to this end.Fig. 1**Selective target-curing of plasmids through *in vivo* meganuclease digestion. (A)** One-step engineering of an I-*Sce*I restriction site into any plasmid of the *Standard European Vector Collection* by site-directed PCR mutagenesis with an oligonucleotide pair carrying the (split) meganuclease recognition target and a sequence homologous to the conserved region between the antibiotic resistance (green) and the *oriT* modules (gray). The asymmetric, 18-bp--long I-*Sce*I restriction sequence is indicated with a pink box, and the overhangs left after digestion are highlighted. Other relevant features of SEVA vectors are identified with different colors. **(B)** Target curing of plasmids in *P*. *putida*. *P. putida* KT2440 carrying plasmids pSEVA228S (XylS/*Pm*→*I-SceI*, Km^R^) and either pS6313·GFP (*P*~*EM7*~→*msfGFP*, Gm^R^) or pS6313·GFPs (*P*~*EM7*~→*msfGFP*, I-*Sce*I site, Gm^R^) was grown for 18 ​h in LB medium with (induced) or without (uninduced) 2 ​mM of 3-methylbenzoate (3-*m*Bz) and Km. Aliquots of these cultures were plated onto solid LB medium, and plasmid loss was determined after 24 ​h by scoring the fluorescence of individual colonies under blue light. The absence of the plasmid was verified by testing colonies for Gm sensitivity. **(C)** Target plasmid curing over time. Cultures of *P. putida* KT2440 containing plasmids pSEVA228S and either pS6313·GFP (indicated as *control*) or pS6313·GFPs were treated with 2 ​mM 3-*m*Bz for the periods indicated and aliquots of the cell suspension were plated onto non-selective solid LB medium. An uninduced control experiment was treated similarly, but 3-*m*Bz was omitted. In all cases, average values for the percentage of plasmid-containing cells and standard deviations are presented, calculated from triplicate measurements from at least three independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

In order to show the general validity of the approach, we constructed plasmid pS6313·GFP, a derivative of vector pSEVA6313 carrying a synthetic module for constitutive expression of *msfGFP* (i.e. *P*~*EM7*~→*msfGFP*). An I-*Sce*I restriction site was engineered in this plasmid, giving rise to plasmid pS6313·GFPs, and this vector was electroporated into strain KT2440. *P. putida* KT2440 carrying either plasmid pS6313·GFP (control vector) or pS6313·GFPs (sensitive to I-*Sce*I digestion) was co-transformed with plasmid pSEVA228S, bearing the meganuclease gene under control of the XylS/*Pm* expression system. Aliquots from these cultures were plated onto non-selective medium after overnight (18 ​h) growth in liquid LB medium added with 3-*m*Bz (to trigger expression of *I-SceI*) under antibiotic selection for plasmid pSEVA228S (Km^R^). After an 18-h incubation, plates were examined under blue light and msfGFP^+^ and msfGFP^--^ colonies were counted to estimate the percentage of plasmid loss. The resulting colonies were replicated onto LB medium plates containing Gm (the antibiotic resistance borne by plasmids pS6313·GFP and pS6313·GFPs) as a further evidence of plasmid presence or loss. Most colonies from 3-*m*Bz--induced cultures of *P*. *putida*/pS6313·GFPs did not show any green fluorescence, while essentially all *P*. *putida*/pS6313·GFPs colonies were highly fluorescent under blue light ([Fig. 1](#fig1){ref-type="fig"}B). In comparison, roughly half of the colonies showed msfGFP fluorescence in a non-induced culture (i.e. no 3-*m*Bz added). Considering the known leakiness of the XylS/*Pm* expression system in the absence of inducer ([@bib31]), the loss of fluorescence in half of these colonies (which matches plasmid loss) is assumed to result from basal expression of the *I-SceI* gene in plasmid pSEVA228S. Importantly, the figures for plasmid loss calculated by the amount of Gm-sensitive clones paralleled the results obtained by scoring msfGFP^--^ colonies.

A time-course experiment was performed to determine the kinetics of target plasmid curing over 30 ​min using *in vivo* meganuclease digestion ([Fig. 1](#fig1){ref-type="fig"}C). The first time point was taken by adding the inducer to the cultures and immediately washing the treated cells with fresh LB medium before plating and colony counting. Surprisingly, exposure of *P*. *putida* to 3-*m*Bz for less than 1 ​min (the minimum time needed for these manipulations) was sufficient to cure plasmid pS6313·GFPs from \~80% of all cells. More than 90% of all cells were cured of the plasmid after induction of *I-SceI* expression for 20 ​min, as indicated by the loss of msfGFP fluorescence. Compared to other plasmid curing systems described in the literature, the kinetics of plasmid loss brought about by this system are considerably fast---probably due to high levels of I-*Sce*I activity and its simple DNA nicking mechanism, which does not require any other components (e.g. cofactors) for efficient DNA restriction ([@bib79]). Taken together, these results expose the validity of the approach for quick and selective curing of plasmids by *in vivo* digestion, but also leave a question mark on the fate of the very plasmid bearing the I-*Sce*I meganuclease module---an issue solved as indicated in the next section.

3.2. Insertion of red fluorescent markers in meganuclease-bearing plasmids {#sec3.2}
--------------------------------------------------------------------------

Target-curing of vectors can be followed by loss of a fluorescence marker (e.g. msfGFP, encoded in vector pSEVA6313·GFPs) or antibiotic sensitivity. In order to facilitate the tracking of the plasmid bearing the I-*Sce*I meganuclease gene (pSEVA228S, Km^R^), easing the identification of plasmid-free cells, we designed and tested a set of synthetic modules encoding different red fluorescent proteins. As the fluorescence intensity of such reporters is known to vary immensely across microbial hosts ([@bib81]), three separate constructs were created, each endowed with different expression strengths and red fluorescence levels ([Fig. 2](#fig2){ref-type="fig"}). In particular, we were interested in red markers that could support visual inspection of bacterial colonies with the naked eye to spot plasmid-free clones. Firstly, the *mCherry* gene, present in a number of SEVA vectors ([@bib95]), was placed under transcriptional control of the constitutive *P*~*EM7*~ promoter and inserted in vector pSEVA228S, which gave rise to plasmid pS228SR·L. Transformation of this low-copy-number plasmid into *E*. *coli* DH5α or *P*. *putida* KT2440 resulted in the lowest level of red fluorescence, as evaluated in colonies grown onto solid LB medium ([Fig. 2](#fig2){ref-type="fig"}A). The monomeric red fluorescent protein (mRFP; [@bib15]) was likewise placed under transcriptional control of the constitutive *P*~*EM7*~ promoter and added to vector pSEVA228S, resulting in plasmid pS228SR·M. Transformation of this plasmid in either bacteria enabled medium mRFP levels ([Fig. 2](#fig2){ref-type="fig"}A). Finally, in order to maximize accumulation of the red fluorescent reporter, *mRFP* was put under transcriptional control of the *P*~*14g*~ promoter (a stronger and constitutive derivative of *P*~*EM7*~) and the gene was added with the *BCD2* translational coupler ([@bib71]; [@bib107]). Addition of this module to vector pSEVA228S resulted in plasmid pS228SR, which conferred the highest level of mRFP accumulation in both *E*. *coli* and *P*. *putida* colonies, easily spotted by naked eye on LB medium plates ([Fig. 2](#fig2){ref-type="fig"}A). To further expand this plasmid toolbox, Gm^R^-derivatives of all three vectors were constructed ([Table 1](#tbl1){ref-type="table"})---allowing the user to combine different vectors for target-curing of plasmids as needed while keeping red fluorescent markers for plasmid tracing. Furthermore, the use of plasmid pS228SR in *P*. *putida* KT2440 enabled the detection of plasmid-containing cells after a mere overnight incubation---whereas red fluorescent markers in other configurations typically needed a further incubation in the cold to enable chromophore maturation ([@bib2]). Direct quantification of the specific red fluorescence in liquid cultures of *E*. *coli* DH5α or *P*. *putida* KT2440 individually transformed with plasmids pS228SR·L (low), pS228SR·M (medium), and pS228SR (high) and grown in LB medium further showed the graded output conferred by the synthetic marker modules ([Fig. 2](#fig2){ref-type="fig"}B). The behavior of the chromophores tested was fairly similar in both hosts, although the low- and medium-level of red fluorescence were comparable in *P*. *putida* (exposing the importance of chromophore maturation, as these measurements were done online during growth). Importantly, plasmid pS228SR resulted in high levels of red fluorescence irrespective of the host (in the case of *P*. *putida*, for instance, the fluorescence signal was \>5-fold higher than that observed when the cells were transformed either with plasmid pS228SR·L or pS228SR·M). The relevant characteristics of this set of meganuclease-bearing vectors are detailed in [Table 2](#tbl2){ref-type="table"}. With these vectors at hand, the next step was to design a protocol for self-curing of plasmids in *P*. *putida*.Fig. 2**Insertion of red fluorescent modules into plasmids carrying the meganuclease gene. (A)** Plasmid pSEVA228S (XylS/*Pm*→*I-SceI*, Km^R^) was used as a template to generate a family of derivatives carrying fluorescent modules yielding low, medium, and high levels of red fluorescence. The modules contain the genes encoding either mCherry or the monomeric red fluorescent protein (mRFP) under transcriptional control of the synthetic, constitutive *P*~*EM7*~ or *P*~*14g*~ promoters. Each gene is preceded by a regulatory element, indicated by a purple circle, composed of a ribosome binding site and a short spacer sequence (5′-AGG AGG AAA AAC AT-3′). For the module yielding high levels of red fluorescence, a bicistronic design (*BCD2*) was used as a translational coupler. *E*. *coli* DH5α and *P*. *putida* KT2440 were transformed with derivatives of plasmid pSEVA228S ([Table 1](#tbl1){ref-type="table"}) and streaked onto LB medium plates containing Km. *E*. *coli* colonies were incubated at 37 ​°C for 18 ​h and photographed afterwards, while *P*. *putida* colonies were grown at 30 ​°C for 18 ​h and plates were stored at 8 ​°C for a further 24 ​h to allow for fluorophore maturation. **(B)** Specific (Sp) red fluorescence in cultures of *E*. *coli* DH5α and *P*. *putida* KT2440 transformed with plasmid pS228SR·L (low), pS228SR·M (medium), or pS228SR (high). Cells were grown in LB medium added with Km for 18 ​h and the Sp red fluorescence, expressed as arbitrary units (AU) relative to the optical density measured at 600 ​nm (OD~600~) of the cultures, was measured after resuspending the bacterial pellets in M9 minimal medium. Each bar represents the mean value of the Sp red fluorescence in each culture ​± ​standard deviation of quadruplicate measurements from at least three independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2Table 2New vectors designed for quick curing of plasmids and quick genome engineering of *Pseudomonas*.Table 2Plasmid[a](#tbl2fna){ref-type="table-fn"}FunctionalityXylS/*Pm*→*I-SceI*Red fluorescenceAntibiotic resistance[b](#tbl2fnb){ref-type="table-fn"}Conditional replicationpS*x*28SR·LYesmCherry; low levelAmp, Km, GmNopS*x*28SR·MYesmRFP; medium levelAmp, Km, GmNopS*x*28SRYesmRFP; high levelKm, GmNopQURE*x*·L/M/HYesmRFP; high levelAmp, Km, GmYes (XylS/*Pm*→*trfA*)[^2][^3]

3.3. Self-curing of plasmids by synthetic control of plasmid replication {#sec3.3}
------------------------------------------------------------------------

We next aimed at applying the plasmid removal approach through *in vivo* DNA digestion to cure the vector bearing *I-SceI*. To this end, we attempted to introduce an I-*Sce*I recognition site into vector pSEVA228S. Even though amplification of the plasmid ([Fig. 1](#fig1){ref-type="fig"}A) and subsequent transformation of *E*. *coli* cells seemed to work well, the resulting plasmids did not contain the correct sequence or the transformants could not be sub-cultured further. We dismissed this strategy after several attempts, and we hypothesized that a plasmid carrying *I-SceI* and its own recognition site is genetically unstable to be maintained even under selective pressure (i.e. antibiotic resistance). This result could be due to the basal expression of *I-SceI*, which was evident in previous experiments ([Fig. 1](#fig1){ref-type="fig"}B), and the phenomenon is probably amplified by the physical proximity of the I-*Sce*I meganuclease to its target, as shown for transcriptional regulators and their cognate promoters ([@bib33]; [@bib102]).

Next, we considered the use of a temperature-sensitive replicon. These replicons are routinely used in *E. coli*, with a well-understood mechanism of plasmid partitioning ([@bib37])---and some reports indicate their use in *P*. *putida* ([@bib19]; [@bib58]; [@bib97]). However, one of the difficulties in using such vectors is that *P*. *putida* KT2440 barely grows when incubated at 42 ​°C ([@bib70])---an incubation condition typically used as non-permissive for temperature-sensitive replicons in *E*. *coli* and other *Pseudomonas* species, e.g. *P*. *aeruginosa* ([@bib86]; [@bib94]). Plasmids designed for recombineering in *E*. *coli* (e.g. the pSIM set of vectors and plasmid pKD46) exploit temperature-sensitive mutants of *oriV*(RK2) and *oriV*(pSC101) ([@bib23]; [@bib98]). While the pSC101 replicon has a very narrow host range and does not replicate in pseudomonads ([@bib9]), the broad-host-range RK2 replicon is known to be functional in *P*. *putida* ([@bib55]). The RK2 replication mechanism depends on the plasmid-encoded replication initiator protein (TrfA) and other elements necessary for replication encoded in the host genome (e.g. DnaA). TrfA binds to the β subunit (sliding clamp) of DNA polymerase III in *E*. *coli* ([@bib56]) and, at the same time, contacts 8-17--bp repeat sequences (iterons) in the *oriV*(RK2), thereby opening the origin of replication. Mutants of RK2, displaying temperature-sensitivity in *E*. *coli*, seem to be stably maintained at elevated temperatures in *P. putida* KT2440. We verified this occurrence by culturing both *E*. *coli* DH5α and *P*. *putida* KT2440 bearing plasmid pFREE-RK2 ([@bib58]) in LB medium at elevated temperatures overnight and checking for plasmid loss through antibiotic sensitivity. The plasmid displayed temperature-sensitivity in *E*. *coli* but replicated in *P*. *putida* at 37 ​°C, yielding a virtually homogenous plasmid-containing bacterial population. This phenomenon could be due to the slow growth of *P*. *putida* at 37 ​°C, but also to high *trfA* expression levels ([@bib82]) and/or enhanced TrfA stability, known to be affected by interactions with host components ([@bib100]).

Dismissing also temperature-sensitive replicons as a strategy for quick curing of plasmids in *P*. *putida*, we focused on engineering a conditionally-replicating vector based on regulated and orthogonal control of the expression of key components of the replication machinery. [@bib51] constructed plasmid pJBSD1 to generate genomic integrations in Gram-negative bacteria ([Table 1](#tbl1){ref-type="table"}), since this vector only replicates in *E. coli* if a chemical inducer is present in the medium. Taking inspiration on this approach, we firstly confirmed the conditional replication of this vector in *P*. *putida* KT2440 by spreading transformants onto LB medium plates with 500 ​μg ​mL^−1^ Amp, with or without 3-*m*Bz as the inducer to trigger the (essential) XylS/*Pm*→*trfA* module expression. Colonies were only obtained on plates added with the chemical inducer, hinting that synthetic control of plasmid replication can be used as a general strategy to manipulate segregational stability of plasmids in *P*. *putida*. This goal was pursued as explained in the next section.

3.4. Target- and self-curing of plasmids in *P*. *putida* {#sec3.4}
---------------------------------------------------------

We proceeded to construct a new set of vectors, termed pQURE, in which plasmid replication is rendered fully dependent on the addition of 3-*m*Bz to the culture medium. Furthermore, we took advantage of red fluorescent markers ([Fig. 2](#fig2){ref-type="fig"}) for plasmid tracing. Plasmid pQURE1·H (Amp^R^) carries the conditional replication machinery (i.e. XylS/*Pm*→*trfA*), an inducible XylS/*Pm*→*I-SceI* module, and a constitutively expressed *P*~*14g*~*(BCD2)*→*mRFP* fluorescence marker. pQURE vectors are designed for both target- and self-curing of plasmids by means of the I-*Sce*I meganuclease in a 3-*m*Bz--dependent fashion ([Fig. 3](#fig3){ref-type="fig"}A). Curing of plasmid pS6313·GFPs from *P. putida* was tested as a proof of concept. To this end, *P. putida* KT2440 was co-transformed with plasmids pS6313·GFPs and pQURE1·H. The first step (target-curing) involved growth of the cells in LB medium containing 2 ​mM 3-*m*Bz for 24 ​h, followed by plating onto LB medium and inspection of the colonies under blue light for msfGFP fluorescence. Under these conditions, 89 ​± ​6% of the cells had lost plasmid pS6313·GFPs ([Fig. 3](#fig3){ref-type="fig"}B). In a consecutive step (self-curing), vector pQURE1·H was eliminated by omitting the inducer and antibiotics in the culture medium. By inoculating an msfGFP^--^ colony into fresh LB medium and incubating the culture for another 24 ​h, 92 ​± ​7% of all cells were cured, with only \~8% of the bacterial population retaining vector pQURE1·H ([Fig. 3](#fig3){ref-type="fig"} B). These traits, visually inspected by the presence of fluorescent markers in individual *P*. *putida* colonies, were confirmed by antibiotic sensitivity in selected clones, yielding similar figures of plasmid-free cells. Taken together, these results expose the high efficiency of the target- and self-curing process. Following the same line of reasoning, we created a whole set of pQURE vectors by combining different determinants of antibiotic resistance and red fluorescent modules ([Table 1](#tbl1){ref-type="table"}).Fig. 3**Target- and self-curing of plasmids by *in vivo* meganuclease digestion with pQURE vectors. (A)** Synthetic control of plasmid replication for target- and self-curing. In pQURE vectors, the gene encoding TrfA (which binds to the vegetative origin of replication, *oriV*) is under transcriptional control of the XylS/*Pm* expression system. pQURE vectors can only replicate in the presence of 3-methylbenzoate (3-*m*Bz), effector of the XylS transcriptional regulator. The *Pm* promoter also drives the expression of the gene encoding the I-*Sce*I meganuclease. When *I-SceI* is expressed, the meganuclease introduces double-strand breaks in any DNA molecule containing its recognition site. In the example, a target plasmid carrying an engineered I-*Sce*I restriction site is recognized by the meganuclease and subjected to *in vivo* digestion---resulting in selective plasmid loss. **(B)***P. putida* KT2440 harboring plasmid pS6313·GFPs was co-transformed with vector pQURE1·H (XylS/*Pm*→*trfA*, Amp^R^). During the first curing step (indicated as 1), cell were grown in LB medium in the presence of 2 ​mM 3-*m*Bz for 18 ​h and aliquots were plated onto solid LB medium. A single colony displaying an msfGFP^--^ phenotype (indicative of loss of plasmid pS6313·GFPs) was inoculated into fresh LB medium without any additives, and grown for 18 ​h (shown as 2). After plating aliquots of this suspension, the percentage of plasmid-free cells as well as the fraction of *P*. *putida* cells carrying plasmids pS6313·GFPs and/or pQURE1·H was calculated as indicated in [Fig. 1](#fig1){ref-type="fig"}. **(C)** Segregational stability of vector pQURE6·H (XylS/*Pm*→*trfA*, Gm^R^) in *P*. *putida* KT2440 over 7--8 generations in LB medium cultures added with varying concentrations (concn.) of 3-*m*Bz in the μM range. The specific (Sp) red fluorescence of these cultures was calculated as indicated in [Fig. 1](#fig1){ref-type="fig"}. Bars represent the mean value of either the percentage of plasmid-containing cells or the Sp red fluorescence in each culture ​± ​standard deviation of quadruplicate measurements from at least three independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

Segregational stability of plasmid pQURE1·H, the replication of which is subjected to the control of the XylS/*Pm* expression system, was studied in the presence of different 3-*m*Bz concentrations. This regulatory system is known to be titratable, and expression levels of genes under control of the *Pm* promoter are also influenced by temperature ([@bib87]). We assumed that pQURE plasmids have to be duplicated at least as quickly as the cells divide in order to be stably retained. Therefore, we explored inducer concentrations in the μM range to determine the minimum amount of 3-*m*Bz that warrants stable plasmid maintenance. Plasmid pQURE1·H was retained in *P*. *putida* KT2440 already in the presence of 8 ​μM 3-*m*Bz ([Fig. 3](#fig3){ref-type="fig"}C). Higher inducer concentrations did not lead to higher fluorescence ([Fig. 3](#fig3){ref-type="fig"}C). Therefore, we assume that (i) the replication machinery is rapidly saturated ([@bib25]) and (ii) the copy number of the plasmid is not titratable, but follows an *ON*/*OFF* behaviour consistent with the replication mechanism of RK2 ([@bib27]). According to this model, replication of RK2 plasmids is strictly dependent on the presence of TrfA, but the machinery is already saturated at low protein concentrations and a further increase of TrfA does not lead to a higher plasmid copy number. Again, the leaky nature of the XylS/*Pm* expression system allowed for some replication of vector pQURE1·H even in the absence of 3-*m*Bz, although addition of the inducer even at very low concentrations resulted in a \~2-fold increase in the red fluorescence output ([Fig. 3](#fig3){ref-type="fig"}C). This expanded plasmid toolbox ([Table 2](#tbl2){ref-type="table"}) served as the basis for practical applications in genome engineering of *P*. *putida* as indicated in the next section.

3.5. Quick genome engineering of pseudomonas with vectors pSNW and pQURE {#sec3.5}
------------------------------------------------------------------------

The most widespread technique for genome engineering of *Pseudomonas* encompasses homologous recombination assisted by the activity of the I-*Sce*I meganuclease ([@bib61], [@bib62]; [@bib104]). This method relies on plasmid-based expression of *I-SceI* for inflicting DSBs in the target chromosome and thus forcing DNA recombination ([Fig. 4](#fig4){ref-type="fig"}A). For most applications, the meganuclease-bearing plasmid has to be cured from mutant clones before further steps can be carried out. Failure to do so results in reduced efficiency of subsequent genome editing steps, as the unavoidable basal expression of *I-SceI* will force recombination while selection pressure for maintaining the resistance marker is applied. In turn, this situation usually leads to the emergence of unwanted mutants (e.g. co-integrants that cannot be resolved, when the I-*Sce*I recognition site acquires mutations that prevent recognition by the meganuclease). The loss-by-dilution protocol routinely used for plasmid curing takes around 4--5 days with \>3 passages in fresh, non-selective medium per day, followed by sensitivity screening of several tens of clones. For mutant strains displaying reduced growth (e.g. after knocking-out key metabolic genes), plasmid curing can take much longer or even being infeasible. Motivated by the ease of target- and self-curing plasmid efficacy of the conditional-replication system, we tested these vectors for fast genome engineering of *P*. *putida*. To this end, the functional elements needed for synthetic control of plasmid replication were combined together with the red fluorescent markers of pQURE vectors as indicated in [Fig. 4](#fig4){ref-type="fig"}A.Fig. 4**Genome engineering of *Pseudomonas* with self-curing vectors and genetic upgrading of suicide plasmids with highly-fluorescent markers. (A)** Genome engineering in *Pseudomonas*. A suicide plasmid \[e.g. from the pGNW or pSNW series, containing the Π-dependent *ori*(*R6K*), [Table 1](#tbl1){ref-type="table"}\] is integrated into the genome of *P*. *putida* through homologous recombination. To this end, homology regions (HR) flanking the gene of interest (*GOI*) are assembled into the plasmid. An msfGFP^+^ clone, harboring a copy of the suicide plasmid co-integrated into the chromosome, is selected and transformed with the pQURE vector of choice ([Table 1](#tbl1){ref-type="table"}) and grown in the presence of 3-methylbenzoate to ensure vector replication and meganuclease activity. I-*Sce*I introduces double-strand breaks in the chromosome and thereby enforces a second homologous recombination event. Resolution of the co-integration leads to either the wild-type or the mutant genotype; msfGP^--^ colonies are screened for the desired alteration and cured from the pQURE vector by growing the cells in the absence of 3-methylbenzoate. **(B)** Genetic upgrading of suicide vector pGNW into pSNW by addition of a bicistronic design in front of *msfGFP*. Bacterial growth **(C)** and specific (Sp) green fluorescence levels **(D)** in *P*. *putida* KT2440 carrying either pGNW2·Δ*benABCD* or pSNW2·Δ*benABCD* (which only differ in the genetic architecture of the fluorescent marker added to the backbone) integrated as a single copy into the target chromosomal locus. Cells were grown in LB medium, and the Sp green fluorescence and the optical density measured at 600 ​nm (OD~600~) was calculated as indicated in [Fig. 1](#fig1){ref-type="fig"}. Data represent the mean value of each parameter ​± ​standard deviation of triplicate measurements from at least five independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 4

We essentially followed the genome engineering strategy by [@bib104] for design and co-integration of suicide plasmids into the *P*. *putida* chromosome. However, we observed a high locus-dependence of the fluorescence intensity brought about by integration of the reporter *msfGFP* gene borne by pGNW vectors ([Fig. S1](#appsec1){ref-type="sec"} in the Supplementary Material). Depending on the genome region, in some cases we could not detect any fluorescence even when the suicide vector had landed in the correct locus. This phenomenon is not surprising, given the highly variable nature of transcriptional activity across the bacterial chromosome ([@bib64]). To address this situation, we upgraded the reporter module of vector pGNW to obtain a reliable fluorescent marker even in low expression loci. The *msfGFP* gene was added with the strong constitutive promoter *P*~*14g*~, and the archetypal ribosome binding site upstream of the coding sequence was replaced by the bicistronic design *BCD2* ([@bib71]; [@bib107]) as a translational coupler ([Fig. 4](#fig4){ref-type="fig"}B). A new set of suicide plasmids for genome engineering was thus created, comprising vectors pSNW2 (Km^R^), pSNW4 (Str^R^), and pSNW6 (Gm^R^) ([Table 1](#tbl1){ref-type="table"}).

We tested the efficiency of these new vectors for genome engineering by targeting the *ben* gene cluster of *P*. *putida* KT2440. Integration of a pGNW2-based suicide vector designed to delete the *ben* genes (i.e. plasmid pGNW·Δ*benABCD*, [Table 1](#tbl1){ref-type="table"}) into this chromosomal locus (*PP_3161*-*PP_3164*) resulted in poorly fluorescent colonies, difficult to spot even when the plates were examined under blue light---given that the *ben* cluster displays very low expression levels in the absence of the cognate aromatic substrates ([@bib53]). The pSNW2-counterpart of this suicide vector (i.e. plasmid pSNW·Δ*benABCD*, [Table 1](#tbl1){ref-type="table"}) was likewise constructed and co-integrated in the chromosome. In this case, successful co-integration events were easily spotted on LB medium plates containing Km by the highly fluorescent phenotype of individual colonies. A single colony was isolated from each set of co-integrants, and bacterial growth and msfGFP fluorescence were determined in LB medium cultures over 24 ​h. While the growth of either *P*. *putida* co-integrant was not affected by the swapping of the fluorescence marker in the suicide plasmid ([Fig. 4](#fig4){ref-type="fig"}C), the msfGFP fluorescence intensity of the co-integrant carrying pSNW·Δ*benABCD* increased by ​\>3-fold ([Fig. 4](#fig4){ref-type="fig"}D). Considering these results, we adopted the pSNW series of plasmids for genome engineering of *P*. *putida*, and carried out deletions by means of the procedure described in the next section.

3.6. Elimination of the *ben* catabolic activities of *P*. *putida* KT2440 {#sec3.6}
--------------------------------------------------------------------------

*P*. *putida* mt-2 carries the catabolic pWW0 plasmid, which endows cells with the ability of processing toluene, xylenes, and ethylbenzene *via* the TOL degradation pathway ([@bib24]). This biochemical route is encoded in two gene clusters, i.e. the upper and the lower or *meta* pathway for degradation of aromatic compounds ([@bib88]). These two biochemical modules convert the hydrocarbon substrate into the corresponding carboxylic acid, and the resulting benzoate(s) are further metabolized to pyruvate and acetaldehyde ([@bib26]). Strain mt-2 also carries a chromosomally-encoded *ortho*-cleavage pathway for benzoate(s) degradation ([@bib46]). When *m*-xylene is processed by the upper pathway, the resulting product is 3-*m*Bz, which can follow alternative metabolic itineraries. The products of either the plasmid-borne *xyl* genes of the lower TOL operon or the chromosomal *ben* genes mediate the transformation of 3-*m*Bz into 3-methylcatechol ([Fig. 5](#fig5){ref-type="fig"}A). *P*. *putida* KT2440 is a derivative of mt-2 that has been cured of the catabolic pWW0 plasmid ([@bib8]; [@bib105]), and therefore processes 3-*m*Bz only through the *ortho*-cleavage pathway. From a practical point of view, spontaneous oxidation and polymerization of 3-methylcatechol gives rise to brown-coloured aggregates ([@bib47]) that interfere with colorimetric and fluorimetry determinations (e.g. bacterial growth as assessed by optical density measurements). Additionally, 3-*m*Bz is employed as a chemical inducer of the XylS/*Pm* expression system---thus hampering the selection of fluorescent colonies in 3-*m*Bz--containing media. As such, we set to eliminate the *ben* gene cluster of *P*. *putida* KT2440 ([Fig. 5](#fig5){ref-type="fig"}B) using the quick genome engineering procedure assisted by self-curing vectors. To this end, the strain carrying plasmid pSNW·Δ*benABCD* as a co-integration in the chromosome ([Fig. 4](#fig4){ref-type="fig"}) was subjected to the procedure outlined in [Fig. 5](#fig5){ref-type="fig"}C. Self-curing vector pQURE6·H ([Table 1](#tbl1){ref-type="table"}) was used as source of the I-*Sce*I meganuclease. Two successive cultivation rounds (firstly, selecting for msfGFP^--^ and mRFP^+^ colonies; secondly, picking clones that have lost all fluorescent markers) sufficed to isolate *P*. *putida* Δ*benABCD* knock-outs in \<2.5 days. The Ben^--^ phenotype was clearly evidenced by the absence of any pigmentation in colonies grown in LB medium added with 3-*m*Bz. Prompted by these encouraging results, we expanded the applications of fast genome engineering approaches for genome reduction of *P*. *putida*.Fig. 5**Elimination of the Ben catabolic activities of *P*. *putida* through quick genome engineering using self-curing pQURE vectors. (A)** The Ben activities mediate the conversion of 3-methylbenzoate (3-*m*Bz) into 3-methylcatechol, which undergoes spontaneous oxidation and polymerization into brown-coloured aggregates. **(B)** Genomic structure of the *ben* locus of *P*. *putida* KT2440. The individual genes within the cluster encode BenA, subunit α of benzoate 1,2-dioxygenase; BenB, subunit β of benzoate 1,2-dioxygenase; BenC, electron transfer component of benzoate 1,2-dioxygenase; and BenD, 1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate dehydrogenase. The Δ symbol identifies the genomic region targeted for deletion. **(C)** Overview of the strategy to delete *benABCD* in *P*. *putida* KT2440 through quick genome engineering. Co-integration of the suicide plasmid pSNW·Δ*benABCD* ([Table 1](#tbl1){ref-type="table"}) into the chromosome can be easily screened for by selecting clones that display a Km^R^ and msfGFP^+^ phenotype. After confirming the genotype of the co-integrants by colony PCR, a clone was further transformed with vector pQURE6·H (XylS/*Pm*→*trfA*, Gm^R^). This strain was grown for 24 ​h in the presence of 2 ​mM 3-*m*Bz, and plated onto solid LB medium to recover msfGFP^--^ and mRFP^+^ colonies. The very few colonies still displaying msfGFP fluorescence (indicated with black arrows) were discarded. Deletion of *benABCD* results in a Ben^--^ phenotype, characterized by the absence of brown pigmentation of colonies in the presence of 3-*m*Bz. To assess this phenotype, colonies were plated onto solid LB medium containing 2 ​mM 3-*m*Bz and incubated at 30 ​°C for 24 ​h. The Ben^+^ (black arrows) or Ben^--^ (white arrows) phenotypes were clearly spotted after storing the plates at 4 ​°C. The final step of the procedure is self-curing of vector pQURE6·H, accomplished by streaking a Ben^--^ colony onto a non-selective medium plate (i.e. neither 3-*m*Bz nor any antibiotic are added). After a 24-h incubation at 30 ​°C, msfGFP^--^ and mRFP^--^ colonies were easily spotted (white arrows) and distinguished from mRFP^+^ clones (still retaining vector pQURE6·H, black arrow) even with the naked eye. Relevant genotypes were confirmed by PCR amplification of the corresponding genomic regions with specific oligonucleotides and DNA sequencing. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 5

3.7. Genome reduction of *P*. *putida* strain EM42 towards a reference *chassis* {#sec3.7}
--------------------------------------------------------------------------------

Capitalizing on the intrinsic physiological and metabolic strength of *P*. *putida* KT2440, [@bib65] sequentially deleted eleven chromosomal regions (comprising 300 genes) to create the reduced-genome strain EM42. This strain displays enhanced physiological properties (e.g. fast growth and increased availability of redox and energy cofactors) that are advantageous for metabolic engineering applications ([@bib5]; [@bib59]). By following a similar line of thought, we further streamlined strain EM42 towards a *P*. *putida* reference *chassis* through fast genome engineering. In particular, we wanted to delete key elements in the chromosome encoding functions that may (i) confer resistance to β-lactam antibiotics, (ii) interfere with the use of fluorescent protein markers, and (iii) hamper the use of 3-*m*Bz as an inducer of the XylS/*Pm* expression system. Inspection of the genome of strain EM42 identified ten genes as obvious targets to fulfil this purpose: eight β-lactamase and β-lactamase--like genes, the siderophore gene *pvdD*, and the *benABCD* gene cluster ([Table 3](#tbl3){ref-type="table"}).Table 3Targets selected for genome engineering of *P*. *putida*.Table 3Gene(s) numberGene(s) nameGenomic region \[bp (strand)\]Length (bp)Annotated function[a](#tbl3fna){ref-type="table-fn"}*PP_1239*1,416,753--1,417,511 (+)759MBLFA[b](#tbl3fnb){ref-type="table-fn"}*PP_3291*3,725,348--3,726,715 (+)1,368MBLFA*PP_1952*2,208,685--2,209,632 (+)948MBLFA*PP_0772*890,074--890,718 (+)645MBLFA*PP_2876ampC*3,276,978--3,278,120 (---)1,143β-lactamase*PP_1775*1,982,049--1,983,482 (+)1,434MBLFA*PP_0052*60,831--61,715 (+)885β-lactamase domain-containing protein*PP_2045*2,325,342--2,327,303 (---)1,962MBLFA*PP_3161-PP_3164benABCD*3,581,930--3,585,749 (+)3,819Benzoate catabolism gene cluster[c](#tbl3fnc){ref-type="table-fn"}*PP_4219pvdD*4,768,854--4,779,266 (---)10,412Non-ribosomal peptide synthetase[^4][^5][^6]

*P*. *putida* exhibits a naturally high resistance to Amp, a hindrance for the use of β-lactams as a selective pressure. Both efflux pumps and β-lactamases account for the resistance of *P. putida* to β-lactam antibiotics. Deletion of the efflux pumps of strain KT2440 increased sensitivity towards these antibiotics, but it also impacted solvent tolerance ([@bib61]). Therefore, we decided to delete the eight genes annotated to encode β-lactamases or metallo-β-lactamase family proteins to reduce Amp resistance without interfering with solvent tolerance. Furthermore, we deleted *pvdD*, encoding a large non-ribosomal peptide synthetase involved in the formation of siderophores ([@bib68]). Siderophores are high-affinity iron-chelating molecules, critical for metal capture in environmental niches colonized by *Pseudomonas* ([@bib21]). The energy- and resource-demanding biosynthesis of these secondary metabolites is not only unnecessary when sufficient iron is supplied (e.g. in laboratory setups), but their presence also interferes with fluorescence measurements. Finally, the Ben catabolic activities were targeted for the reasons explained in the preceding section. The genes encoding these features are spread over the bacterial chromosome ([Fig. 6](#fig6){ref-type="fig"}A). Again, 500-bp long homologous regions flanking the target were amplified with the corresponding set of primers for each knock-out ([Table S1](#appsec1){ref-type="sec"}) and inserted into the suicide plasmid pSNW2 according to the procedure of [@bib104] indicated in [Fig. 4](#fig4){ref-type="fig"}A. After plasmid co-integration, the resulting strains were transformed with vector pQURE6·H and cells were recovered for 2 ​h in LB medium with 2 ​mM 3-*m*Bz. For all targets, the efficiency of co-integration resolving was \>90% and, in several cases, close to 100%. Elimination of all the genes listed in [Table 3](#tbl3){ref-type="table"} led to a \~23-kb reduction of the genome of strain EM42, giving rise to streamlined *P*. *putida* strain SEM10 (i.e. lacking 310 genes as compared to wild-type strain KT2440). To test whether off-target mutations were introduced due to the multi-step genome engineering programme, we carried out a suite of colony PCR amplifications in the parental strain (EM42) and its SEM10 derivative. All the amplicons had the expected size, and sequencing of these DNA fragments confirmed the absence of any unintended mutation ([Fig. S2](#appsec1){ref-type="sec"} in the Supplementary Material).Fig. 6**Streamlining reduced-genome *P*. *putida* strain EM42 by quick genome engineering using self-curing pQURE vectors. (A)** Operons and genomic regions deleted in *P*. *putida* EM42. The position and the relative orientation of the eleven gene(s)/genome regions eliminated is indicated in the physical map of the chromosome ([Table 3](#tbl3){ref-type="table"}). Genes encoding β-lactamases or metallo-β-lactamase family proteins are indicated in red. **(B)** Ampicillin sensitivity of *P*. *putida* EM42 and its reduced-genome derivative *P*. *putida* SEM10. Ten-fold dilutions of the cultures were spotted onto LB medium plates containing ampicillin at the concentrations (concn.) indicated, and plates were photographed after incubation at 30 ​°C for 24 ​h. **(C)** Comparison of the growth of both strains in LB medium (left panel) and M9 minimal medium containing 0.2% (w/v) citrate (right panel). The optical density measured at 600 ​nm (OD~600~) of these cultures was recorded over 24 ​h, and data represent the mean value of the OD~600~ readings ​± ​standard deviation of triplicate measurements from at least three independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 6

*P*. *putida* SEM10 was then subjected to phenotypic characterization by examining growth profiles in different culture conditions and antibiotic resistance. Expectedly, the reduced-genome strain displayed increased susceptibility towards Amp ([Fig. 6](#fig6){ref-type="fig"}B). Importantly, no colonies of *P*. *putida* SEM10 were observed when dilutions of the cell suspension were spotted in LB medium plates containing 75 ​μg ​mL^−1^ Amp---allowing for the use of Amp^R^ as a selection marker at antibiotic concentrations similar to those employed for *E*. *coli*. The deletion of *benABCD* suppressed the development of pigments derived from 3-methylcatechol in cultures of *P*. *putida* SEM10 grown in the presence of 3-*m*Bz. Furthermore, autofluorescence of this genome-reduced strain was highly reduced due to the deletion of *pvdD*. Finally, no changes were observed in the growth profile of this strain in rich LB medium or minimal M9 medium containing 0.2% (w/v) citrate as compared to *P. putida* EM42 ([Fig. 6](#fig6){ref-type="fig"}C), indicating that the deletions introduced in this study are largely irrelevant for fitness under laboratory conditions.

4. Conclusion {#sec4}
=============

In this work, we have benchmarked a toolbox for target- and self-curing of plasmids in *Pseudomonas*. Although the literature offers numerous examples of circuits and strategies developed to ensure plasmid maintenance in cell factories ([@bib57]; [@bib74]; [@bib96]), less attention has been paid to the equally important programmable loss of plasmids. After assessing vector curing methods commonly used in other bacterial species ([@bib35]; [@bib39]; [@bib49]), we failed to identify a straightforward procedure that can be applied to *P*. *putida*.

Recently, [@bib58] developed an elegant approach to plasmid curing based on CRISPR/Cas9, reaching a vector loss efficiency of \~40--90% in *E*. *coli* within 24 ​h. This system relies on the Cas9 nuclease, which can cause inadvertent off-target mutations in the genome ([@bib80]) and is known to be a toxic protein when the cognate gene is expressed heterologously ([@bib106]). On the other hand, the efficiency and editing-accuracy of CRISPR/Cas9-based systems varies even between closely related bacterial species ([@bib101]). Most importantly, this system and other genome engineering tools ([@bib19]; [@bib97]), employ a temperature-sensitive *oriV*(RK2), which, in our hands, does not exhibit a consistent temperature-dependent replication behaviour in *P*. *putida* KT2440. The procedure developed in this study, based on *in vivo* digestion of vectors by the I-*Sce*I meganuclease (i.e. target-curing) and synthetic control of plasmid replication (i.e. self-curing), is fast, plasmid-specific, and can be applied in virtually any microorganism where the use of temperature-sensitive replicons is not possible. Importantly, the plasmid-curing step during genome engineering, typically consuming several days during the routine loss-by-dilution protocol, has been brought down to a mere overnight cultivation in a simple culture medium (omitting 3-*m*Bz in its formulation). Owing to the presence of red fluorescent markers in pQURE vectors (the output level of which can be selected according to the application), laborious sensitivity screenings are fully circumvented. Furthermore, for applications were achieving a vector loss efficiency of 100% is crucial, plasmid-free bacteria can be automatically isolated by fluorescence-activated cell sorting. Note that the procedure presented herein can be (i) scaled-up as needed, whereas temperature shifts for plasmid curing are meaningful only at the laboratory scale, and (ii) used in other Gram-negative bacteria besides *Pseudomonas*.

YEJPN_press_logoThe adoption of the quick genome engineering, assisted by self-curing pQURE vectors, enabled the construction of a reduced-genome, streamlined variant of *P*. *putida* KT2440, termed strain SEM10. The genome of *P*. *putida* SEM10 has been shortened by 4.76% as compared to wild-type strain KT2440, and the phenotypes of this platform bacterium (e.g. absence of siderophore-related autofluorescence and sensitivity to β-lactams) can be exploited for several applications both in the laboratory and in industrial setups. Importantly, the elimination of all β-lactamase--encoding genes \[typically associated with horizontal gene transfer of antibiotic resistance and pathogenicity ([@bib90])\] enhances the biosafety of *P*. *putida* for metabolic engineering applications. Further genome reduction of strain SEM10 towards a reference *chassis* is currently underway in our laboratory---an overarching objective calling for quick genome engineering approaches that shorten the turnaround typically needed when manipulating non-conventional microorganisms.
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[^1]: Antibiotic markers: Amp, ampicillin; Gm, gentamicin; Km, kanamycin; Nal, nalidixic acid; and Str, streptomycin. HRs, homology regions.

[^2]: The letter *x* indicates different antibiotic resistance markers \[coded as per the *Standard European Vector Architecture* rules ([@bib95])\], and the suffix L, M, or H specifies low, medium, or high red fluorescence (mRFP/mCherry) levels, respectively.

[^3]: Antibiotic markers: Amp, ampicillin; Gm, gentamicin; and Km, kanamycin.

[^4]: Functional annotations and genome coordinates are given according to the *Pseudomonas* Database ([@bib103]) and [@bib11].

[^5]: MBFA, metallo-β-lactamase family protein.

[^6]: The enzymes encoded in the *ben* gene cluster are BenA, subunit α of benzoate 1,2-dioxygenase; BenB, subunit β of benzoate 1,2-dioxygenase; BenC, electron transfer component of benzoate 1,2-dioxygenase; and BenD, 1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate dehydrogenase.
